How rare is myelofibrosis?

Myelofibrosis is a rare blood cancer. The American Cancer Society estimates that about 1,500 to 2,000 people in the United States will be diagnosed with myelofibrosis in 2023. This makes myelofibrosis about as common as leukemia and multiple myeloma.

Myelofibrosis is more common in men than in women, and it is most often diagnosed in people between the ages of 50 and 70. However, myelofibrosis can occur at any age.

The exact cause of myelofibrosis is unknown, but it is thought to be related to a combination of genetic and environmental factors. Some people with myelofibrosis have a family history of the disease, while others have been exposed to certain chemicals or radiation.

Myelofibrosis can be a serious disease, but it can be managed with treatment. The main goal of treatment is to relieve symptoms and improve quality of life. Treatment options may include medication, surgery, and stem cell transplant.